Both in Pharmaceuticals
Septerna vs Palvella Therapeutics
Over the past year SEPN returned +118.0% and PVLA returned +99.0%; their daily moves had a correlation of 0.38.
SEPN +118.0% PVLA +99.0%Growth of $1, one year, split-adjusted
| Metric | SEPN | PVLA |
|---|---|---|
| Price | $43.70 | $152.93 |
| Market cap | $2.04B | $2.20B |
| Today | +1.16% | +4.51% |
| 1 month | +15.4% | +15.7% |
| 6 months | +81.1% | +18.1% |
| Year to date | +56.7% | +46.1% |
| 1 year | +112.1% | +91.5% |
| Revenue growth (YoY) | +22375.6% | — |
| Gross margin | 100.0% | — |
| Net margin | −48.7% | — |
| P/E (TTM) | — | — |
| Price / sales | 20.6× | — |
| Net cash | $372.3M | $250.6M |
| Dividend yield | — | — |
| Volatility (60d) | 62.0% | 47.2% |
| Short % of float | 12.0% | 21.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).